A phase III trial evaluating Cadonilimab in gastric or gastroesophageal junction cancer
Latest Information Update: 06 Jul 2022
At a glance
- Drugs Cadonilimab (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
Most Recent Events
- 06 Jul 2022 New trial record